New quinazoline-N-4-fluorophenyl derivatives as potential anticancer agents: Discovery of a promising dual EGFR/VEGFR-2 inhibitor
Year: 2024, Volume: 36, Issue: 11, November
Disclaimer:
This article was originally published by Elsevier and was migrated to Scientific Scholar after the change of Publisher.
This article was originally published by Elsevier and was migrated to Scientific Scholar after the change of Publisher.